Clinical Trial Update: Detection of Chromosomal Aberrations in Non-small Cell Lung Cancer (NSCLC) Using Fluorescent in Situ Hybridization (FISH) (ALK Test)

View source ↗

Summary

A completed clinical trial evaluating detection of chromosomal aberrations in non-small cell lung cancer using Fluorescent in Situ Hybridization (FISH) for ALK …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Applied Spectral Imaging Ltd. | Conditions: Non-small Cell Lung Cancer (NSCLC) | Status: COMPLETED